1039 related articles for article (PubMed ID: 15673802)
1. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
Arad M; Maron BJ; Gorham JM; Johnson WH; Saul JP; Perez-Atayde AR; Spirito P; Wright GB; Kanter RJ; Seidman CE; Seidman JG
N Engl J Med; 2005 Jan; 352(4):362-72. PubMed ID: 15673802
[TBL] [Abstract][Full Text] [Related]
2. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.
Arad M; Benson DW; Perez-Atayde AR; McKenna WJ; Sparks EA; Kanter RJ; McGarry K; Seidman JG; Seidman CE
J Clin Invest; 2002 Feb; 109(3):357-62. PubMed ID: 11827995
[TBL] [Abstract][Full Text] [Related]
3. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy.
Arad M; Moskowitz IP; Patel VV; Ahmad F; Perez-Atayde AR; Sawyer DB; Walter M; Li GH; Burgon PG; Maguire CT; Stapleton D; Schmitt JP; Guo XX; Pizard A; Kupershmidt S; Roden DM; Berul CI; Seidman CE; Seidman JG
Circulation; 2003 Jun; 107(22):2850-6. PubMed ID: 12782567
[TBL] [Abstract][Full Text] [Related]
4. A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosis.
Laforêt P; Richard P; Said MA; Romero NB; Lacene E; Leroy JP; Baussan C; Hogrel JY; Lavergne T; Wahbi K; Hainque B; Duboc D
Neuromuscul Disord; 2006 Mar; 16(3):178-82. PubMed ID: 16487706
[TBL] [Abstract][Full Text] [Related]
5. Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the gamma2-subunit of AMP-activated protein kinase.
Akman HO; Sampayo JN; Ross FA; Scott JW; Wilson G; Benson L; Bruno C; Shanske S; Hardie DG; Dimauro S
Pediatr Res; 2007 Oct; 62(4):499-504. PubMed ID: 17667862
[TBL] [Abstract][Full Text] [Related]
6. Single-gene mutations and increased left ventricular wall thickness in the community: the Framingham Heart Study.
Morita H; Larson MG; Barr SC; Vasan RS; O'Donnell CJ; Hirschhorn JN; Levy D; Corey D; Seidman CE; Seidman JG; Benjamin EJ
Circulation; 2006 Jun; 113(23):2697-705. PubMed ID: 16754800
[TBL] [Abstract][Full Text] [Related]
7. Danon disease as an underrecognized cause of hypertrophic cardiomyopathy in children.
Yang Z; McMahon CJ; Smith LR; Bersola J; Adesina AM; Breinholt JP; Kearney DL; Dreyer WJ; Denfield SW; Price JF; Grenier M; Kertesz NJ; Clunie SK; Fernbach SD; Southern JF; Berger S; Towbin JA; Bowles KR; Bowles NE
Circulation; 2005 Sep; 112(11):1612-7. PubMed ID: 16144992
[TBL] [Abstract][Full Text] [Related]
8. An atypical variant of Fabry's disease in men with left ventricular hypertrophy.
Nakao S; Takenaka T; Maeda M; Kodama C; Tanaka A; Tahara M; Yoshida A; Kuriyama M; Hayashibe H; Sakuraba H
N Engl J Med; 1995 Aug; 333(5):288-93. PubMed ID: 7596372
[TBL] [Abstract][Full Text] [Related]
9. [Cardiomyopathies due to defective energy metabolism: morphological and functional features].
Giordano C; D'Amati G
Pathologica; 2005 Dec; 97(6):361-8. PubMed ID: 16619977
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.
Niimura H; Bachinski LL; Sangwatanaroj S; Watkins H; Chudley AE; McKenna W; Kristinsson A; Roberts R; Sole M; Maron BJ; Seidman JG; Seidman CE
N Engl J Med; 1998 Apr; 338(18):1248-57. PubMed ID: 9562578
[TBL] [Abstract][Full Text] [Related]
11. Sarcomere protein gene mutations in patients with apical hypertrophic cardiomyopathy.
Gruner C; Care M; Siminovitch K; Moravsky G; Wigle ED; Woo A; Rakowski H
Circ Cardiovasc Genet; 2011 Jun; 4(3):288-95. PubMed ID: 21511876
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel LAMP2 mutation responsible for X-chromosomal dominant Danon disease.
Horváth J; Ketelsen UP; Geibel-Zehender A; Boehm N; Olbrich H; Korinthenberg R; Omran H
Neuropediatrics; 2003 Jun; 34(5):270-3. PubMed ID: 14598234
[TBL] [Abstract][Full Text] [Related]
13. Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency.
Burwinkel B; Scott JW; Bührer C; van Landeghem FK; Cox GF; Wilson CJ; Grahame Hardie D; Kilimann MW
Am J Hum Genet; 2005 Jun; 76(6):1034-49. PubMed ID: 15877279
[TBL] [Abstract][Full Text] [Related]
14. Danon's disease as a cause of hypertrophic cardiomyopathy: a systematic survey.
Charron P; Villard E; Sébillon P; Laforêt P; Maisonobe T; Duboscq-Bidot L; Romero N; Drouin-Garraud V; Frébourg T; Richard P; Eymard B; Komajda M
Heart; 2004 Aug; 90(8):842-6. PubMed ID: 15253947
[TBL] [Abstract][Full Text] [Related]
15. Danon disease: focusing on heart.
Cheng Z; Fang Q
J Hum Genet; 2012 Jul; 57(7):407-10. PubMed ID: 22695892
[TBL] [Abstract][Full Text] [Related]
16. Nodoventricular accessory pathways in PRKAG2-dependent familial preexcitation syndrome reveal a disorder in cardiac development.
Tan HL; van der Wal AC; Campian ME; Kruyswijk HH; ten Hove Jansen B; van Doorn DJ; Oskam HJ; Becker AE; Wilde AA
Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):276-81. PubMed ID: 19808419
[TBL] [Abstract][Full Text] [Related]
17. Glycogen storage diseases and cardiomyopathy.
Roos JC; Cox TM
N Engl J Med; 2005 Jun; 352(24):2553; author reply 2553. PubMed ID: 15958815
[No Abstract] [Full Text] [Related]
18. Danon disease: a focus on processing of the novel LAMP2 mutation and comments on the beneficial use of peripheral white blood cells in the diagnosis of LAMP2 deficiency.
Majer F; Vlaskova H; Krol L; Kalina T; Kubanek M; Stolnaya L; Dvorakova L; Elleder M; Sikora J
Gene; 2012 May; 498(2):183-95. PubMed ID: 22365987
[TBL] [Abstract][Full Text] [Related]
19. Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy.
Richard P; Isnard R; Carrier L; Dubourg O; Donatien Y; Mathieu B; Bonne G; Gary F; Charron P; Hagege M; Komajda M; Schwartz K; Hainque B
J Med Genet; 1999 Jul; 36(7):542-5. PubMed ID: 10424815
[TBL] [Abstract][Full Text] [Related]
20. Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history.
Murphy RT; Mogensen J; McGarry K; Bahl A; Evans A; Osman E; Syrris P; Gorman G; Farrell M; Holton JL; Hanna MG; Hughes S; Elliott PM; Macrae CA; McKenna WJ
J Am Coll Cardiol; 2005 Mar; 45(6):922-30. PubMed ID: 15766830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
